CTG PHARMA S.R.L.
|CTG PHARMA S.R.L. Patent applications|
|Patent application number||Title||Published|
|20100168216||PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS - The present invention relates to new prostaglandin derivatives having improved pharmacological activity and enhanced tolerability. They can be employed for the treatment of glaucoma and ocular hypertension.||07-01-2010|
|20090281093||ANTI-INFLAMMATORY COMPOUNDS - The present invention relates to novel non steroidal anti-inflammatory compounds (NSAIDs) that release hydrogen sulfide (H||11-12-2009|
|20090275539||Nuclear Transcription Factors Regulators - The present invention relates to novel compounds that are nuclear transcription factors (NTF) regulators. The present invention also provides methods for treating, preventing and/or reducing inflammation associated diseases by regulating NTF in the cardiovascular, connective tissue, pulmonary, gastrointestinal, respiratory, urogenital, nervous, or cutaneous systems as well as tumoral and infective diseases employing said compounds.||11-05-2009|
|20090036516||COMPOUNDS FOR TREATING METABOLIC SYNDROME - Compounds of general formula:||02-05-2009|
|20080262031||4-Aminoquinoline Derivatives as Antimalarials - New 4-aminoquinoline derivatives having the general formula (I) wherein R, M, X, Y and T have the meaning described in the specification, as potent antimalarials active also on chloroquine-resistant||10-23-2008|
Patent applications by CTG PHARMA S.R.L.